November 21, 2017

Gene Test Improves Coumadin (warfarin) Use for Stroke Prevention in Atrial Fibrillation (AF)

Genetic tests that show high or low sensitivity to blood thinner (anticoagulant) drugs like warfarin (Coumadin) not only improve dosing accuracy but also reduce hospitalization by 31%, according to a new study just presented at the American College of Cardiology scientific sessions. Coumadin is often prescribed for people who have afib to prevent blood clots that can cause strokes.

Read more:  Gene Test Improves Use of Coumadin (warfarin) for Stroke Prevention in Atrial Fibrillation

Comments

  1. jean jurkiewicz says:

    So every person does not have the same INR lines as everyone else does. My husband was kept within the usual inr lines but had a lot of allergy problems and a nose bleed for a year. He was never taken off of the warafin and died in Sept. 2010

Comment